7
total announcements
512600.BO · 15 min delayed
Astal Laboratories Ltd
Astal Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/09/2026 to consider and approve the Notice of 33rd Annual General Meeting, Board Report, and other matters.
Astal Laboratories Ltd
Astal Laboratories Ltd has published its unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Astal Laboratories Ltd
Astal Laboratories Ltd has submitted a statement of deviation and variation in the utilization of funds raised through preferential issues and rights issues. The company has not reported any deviation or variation in the use of funds for the quarter ended 30th June 2026.
Astal Laboratories Ltd
Astal Laboratories Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's revenue from operations was ₹2,532.66 lakhs, with total revenue standing at ₹2,538.27 lakhs. Expenses included cost of material consumed, purchases of stock-in-trade, change in inventories, and employees' benefits expenses.
Astal Laboratories Ltd
Astal Laboratories Ltd has announced its unaudited standalone financial results for the quarter ended 30th June, 2026. The company's revenue from operations was Rs. 3,95,147 lakhs, and its total revenue was Rs. 3,954.62 lakhs. The company's expenses, including cost of material consumed, were Rs. 4,087.52 lakhs.
Astal Laboratories Ltd
Astal Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve prior intimation of the board meeting, unaudited standalone & consolidated financial results for the quarter ended 30th June, 2026, and limited review report of the auditors.
Astal Laboratories Ltd
Astal Laboratories Ltd has submitted its initial disclosure as per SEBI's "Large Corporate Framework." The company has confirmed that it does not fall under the Large Corporate category for the Financial Year 2025-2026, making the provisions of the related SEBI circular inapplicable to them. This filing includes details of outstanding borrowings as part of the disclosure format.